Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lemaitre Vascular Inc gives Q2 2014 guidance below analysts' estimates; lowers FY 2014 revenue guidance; reaffirms FY 2014 operating income guidance


Tuesday, 29 Apr 2014 04:05pm EDT 

Lemaitre Vascular Inc:Expects Q2 2014 sales of $17.6 million and operating income of $1.0 million.Expects FY 2014 sales of $70.0 million and operating income of $5.5 million.Q2 2014 revenue of $17.7 million and EBIT of $1.4 million - Thomson Reuters I/B/E/S.FY 2014 revenue of $70.2 million and EBIT of $5.5 million - Thomson Reuters I/B/E/S. 

Company Quote

7.33
0.13 +1.81%
19 Dec 2014